MX1 and COVID-19: Zhu et al. found that interferon-stimulated genes (such as ISG15, IFI44L, and MX1) in the peripheral blood immune cells of patients with COVID-19 were significantly upregulated, which confirmed that the innate immune response was significantly activated in patients with COVID-19.